These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 513358)

  • 41. [HB antigen incidence in families of children with chronic hepatitis].
    Karasińska M; Machalska M
    Pediatr Pol; 1977 Sep; 52(9):977-82. PubMed ID: 917627
    [No Abstract]   [Full Text] [Related]  

  • 42. Pattern of occurrence of HBeAg and anti-HBe among blood donors and patients with liver diseases in Tamil Nadu.
    Thyagarajan SP; Subramaniam S; Solomon S; Panchanadam M; Madanagopalan N
    Indian J Med Res; 1980 Feb; 71():309-15. PubMed ID: 7380507
    [No Abstract]   [Full Text] [Related]  

  • 43. [HBV serologic markers in the chronic alcoholism (author's transl)].
    Todeschini G; Frandi G; Vicari O; Bontempelli M; Cavagnera A
    Quad Sclavo Diagn; 1981 Jun; 17(2):123-9. PubMed ID: 7267976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY; Sung JL
    J Med Virol; 1986 Apr; 18(4):301-7. PubMed ID: 2940332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on HBs-Ag clustering families (author's transl)].
    Yamaguchi K; Hashimoto S
    Rinsho Byori; 1975 Sep; 23(9):693-6. PubMed ID: 1237650
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum hepatitis (SH) antigen amongst patients with liver diseases and voluntary blood donors--a prospective study.
    Pal SR; Dutta DV; Choudhury S; Jolly JG; Deodhar SD; Samant AK; Chitkara NL; Chuttani PN
    Indian J Med Res; 1973 Dec; 61(12):1784-98. PubMed ID: 4787035
    [No Abstract]   [Full Text] [Related]  

  • 47. [Histological follow-up of latent chronic liver diseases in an area with endemic liver cancer and liver cirrhosis (Tomie-Cho, Goto Island, Nagasaki Prefecture].
    Munehisa T; Nakata K; Muro T; Kohno K; Furukawa R; Kusumoto Y; Nagataki S; Ishii N; Koji T; Iwanaga A
    Nihon Shokakibyo Gakkai Zasshi; 1982 Aug; 79(8):1576-80. PubMed ID: 7176149
    [No Abstract]   [Full Text] [Related]  

  • 48. Epidemiological studies of alpha-fetoprotein and hepatitis B antigen in Tomié Town, Nagasaki, Japan.
    Koji T; Munehisa T; Yamaguchi K; Kusumoto Y; Nakamura S
    Ann N Y Acad Sci; 1975 Aug; 259():239-47. PubMed ID: 54026
    [No Abstract]   [Full Text] [Related]  

  • 49. Diseases of the alimentary system. Significance of persistent HBs antigenaemia.
    Woolf IL; Williams R
    Br Med J; 1976 Oct; 2(6039):807-8. PubMed ID: 974623
    [No Abstract]   [Full Text] [Related]  

  • 50. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain.
    Viola LA; Barrison IG; Coleman JC; Paradinas FJ; Fluker JL; Evans BA; Murray-Lyon IM
    Lancet; 1981 Nov; 2(8256):1156-9. PubMed ID: 6118590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Asymptomatic chronic-persisting hepatitis B in a young child as source of infection of hepatitis B within a family (author's transl)].
    Schober A; Manthei U; Kaboth U; Winckler R; Biswas R; Gerlich W; Hierholzer E; Stamm B
    Dtsch Med Wochenschr; 1978 Apr; 103(14):623-6. PubMed ID: 639697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory test of serum samples from various forms of liver disease on the e system associated with hepatitis B.
    Mai K; Xie CY
    Chin Med J (Engl); 1979 Oct; 92(10):709-18. PubMed ID: 116812
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatitis-B virus determinant in patients with liver disease in Malawi.
    Molyneux ME; Supran EM; Islam MN; Banatvala JE; Hutt MS
    Trans R Soc Trop Med Hyg; 1980; 74(3):383-8. PubMed ID: 6254218
    [No Abstract]   [Full Text] [Related]  

  • 56. Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity.
    Maynard JE; Barrett DH; Murphy BL; Bradley DW; Berquist KR; Bender TR
    J Infect Dis; 1976 Mar; 133(3):339-42. PubMed ID: 56411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Methodological problems of Hepatitis B Virus carriership detection (author's transl)].
    Pintera J
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):108-27. PubMed ID: 149604
    [No Abstract]   [Full Text] [Related]  

  • 58. [An epidemiologic study of hepatitis B virus in Yaeyama, Okinawa].
    Hayashi J
    Fukuoka Igaku Zasshi; 1984 Jul; 75(7):431-44. PubMed ID: 6500477
    [No Abstract]   [Full Text] [Related]  

  • 59. [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].
    Knolle J; Born M; Hess G; Klinge O; Arnold W; Bitz H; Meyer KH
    Klin Wochenschr; 1976 Jun; 54(12):567-78. PubMed ID: 781393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.